Screener
Rhythm Pharmaceuticals, Inc. RYTM Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s current ratio?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported current ratio of 4.2× in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s current ratio increased by 26.2% year-over-year, from 3.3× to 4.2×.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s current ratio has grown at a -15.3% compound annual growth rate (CAGR), from 10.1× to 4.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude